Tag Archives: European Union
By Guest Blogger | Published: August 29, 2012
The European Union’s proposed health technology assessment network to encourage “cooperation and exchange of scientific information among member states” is a significant step, says Reflector. But, as far as standardizing an approach to value is concerned, will it be a damp squib?
By Guest Blogger | Published: July 30, 2012
Patient groups are a growing force, not just in the debate around tactical areas of medical specialities, but also on the vital question of pricing and reimbursement rules. But will their voices be heard? Reflector reports. An important third party is struggling to make its voice heard in European pharma discussions. Drug pricing is not just [...]
By Guest Blogger | Published: May 24, 2012
Will France’s new socialist president, François Hollande, prove too strong for pharma’s taste? Reflector, Pharm Exec’s EU correspondent, reports. So it has happened. A leading European country has gone against the predominant political grain, and elected a socialist head of state. France is now ruled by François Hollande, a mild-mannered but avowedly drug-industry-skeptical president. Is the [...]
By Guest Blogger | Published: October 5, 2011
This month sees Pharmaceutical Executive magazine reach its 30th birthday. In line with that milestone, Reflector assesses what the last three decades have meant for European pharma — and shows how the game has changed beyond recognition. Thirty years is a long time in any industry. The coalmining industry, the market for air travel, or telecommunications [...]
By Guest Blogger | Published: July 27, 2011
Reflector finds some surprising common ground in what should be two very different HTA reports. Just like with buses, you wait for ages for an international review of health technology assessment to come along, then two turn up at once.